Terry Opgenorth, PhD
Terry has been with CSUV since 2007. He spent 20 years with Abbott Laboratories (now AbbVie) as the Vice President of Metabolic Disease, Antiviral and Target-Lead Discovery Research for its Global Pharmaceutical Division.He was President/CEO of Vidasym, and is CSO/Co-Founder of VetDC. Terry serves as an Independent Board Director for Vidasym, KromaTiD, VetDC, and UNeMed.
He previously served as Co-Founder/Advisor to the Colorado Center for Drug Discovery (C2D2) and Board Director for CID4, CBS and Keystone Symposia . Dr. Opgenorth holds a BA from Calvin College and MS and PhD degrees from University of Illinois Urbana-Champaign.